[
    [
        {
            "time": "",
            "original_text": "抗 癌 “ 姐 妹 花 ”：继 凯 美 纳 后  贝 达 药 业 又 一 款 T K I 获 批",
            "features": {
                "keywords": [
                    "抗癌",
                    "凯美纳",
                    "贝达药业",
                    "TKI",
                    "获批"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "抗 癌 “ 姐 妹 花 ”：继 凯 美 纳 后  贝 达 药 业 又 一 款 T K I 获 批",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]